1,654
Views
28
CrossRef citations to date
0
Altmetric
Review Article

Stimuli-sensitive Systems-an emerging delivery system for drugs

, , &
Pages 299-310 | Received 30 Sep 2013, Accepted 13 Oct 2013, Published online: 12 Nov 2013

References

  • Abraham S, Furtado S, Bharath S, Basavaraj BV, Deveswaran R, Madhavan V. 2009. Sustained ophthalmic delivery of ofloxacin from an ion-activated In situ gelling system. Pak J Pharm Sci. 22:175–179.
  • Alexander C. 2006. Temperature and pH-responsive smart polymers for gene delivery. Expert Opin Drug Deliv. 3:573–581.
  • Alfonso M, Kirilovsky D. 2000. Redox control of psbA gene expression in the cyanobacterium synechocystis PCC 6803. Involvement of the cytochrome b6/f complex. Plant Physiol. 122:505–515.
  • Aluri S, Janib SM, Mackay JA. 2009. Environmentally responsive peptides as anticancer drug delivery system. Adv Drug Deliver Rev. 61:940–952.
  • Arndt D, Zeisig R, Eue I, Sternberg B, Fichtner I. 1997. Antineoplastic activity of sterically stabilized alkyl phosphocholine liposomes in human breast carcinomas. Breast cancer Res Treat. 43:237–246.
  • Atyabi F, Khodaverdi E, Dinarvand R. 2007. Temperature modulated drug permeation through liquid crystal embedded cellulose membranes. Int J Pharm. 339:213–221.
  • Aznar E, Casasus R, García-Acosta B, Marcos MD, Martínez-Manez R, Sancenon F, et al. 2007. Photochemical and chemical two-channel control of functional nanogated hybrid architectures. Adv Mater. 19:2228–2231.
  • Balasubramaniam J, Kant S, Pandit JK. 2003. In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin. Acta Pharm. 53:251–261.
  • Bikram M, West JL. 2008. Thermoresponsive system for controlled drug delivery. Expert Opin Drug Deliv. 5:1077–1091.
  • Carreira AS, Gonçalves FAMM, Mendonça PV, Gil MH, Coelho JFJ. 2010. Temperature and pH responsive polymers based on chitosan: Applications and new graft copolymerization strategies based on living radical polymerization. Carbohydr Polym. 80:618–630.
  • Chen CC, Fang CL, Suwayeh AS, Leu YL, Fang JY. 2011. Transdermal delivery of selegiline from alginate-Pluronic composite thermogels. Int J Pharm. 415:119–128.
  • Couvrer P, Vouthier C. 2006. Nanotechnology: intelligent design to treat complex disease. Pharm Res. 23:1417–1450.
  • Deshmukh PK, Fursule RA. 2010. Study of a novel environmentally responsive ophthalmic Drug delivery system. Int J Pharm Bio Sci. 6:211–219.
  • Dufresne MH, Garrec DL, Sant V, Leroux JC, Ranger M. 2004. Preparation and characterization of water-soluble pH sensitive nanocarriers for drug delivery. Int J Pharm. 277:81–90.
  • Dzulkefli NA. 2008. Fabrication of gluocose sensitive actuator for DDS Microvalve. ICSE.227–231.
  • Fadel M. 2007. Photpdynamic efficiency of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells. J Control Release. 143:78–89.
  • Ganta S, Devalapally H, Shahiwala A, Amiji M. 2008. A review of stimuli-responsive nanocarriers for drug and gene delivery. J Control Release. 126:187–204.
  • Gupta P, Vermani K, Garg S. 2002. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today. 7:569–579.
  • Hinrichs WL, Suhuurmans NM. 1999. Thermosensitive polymers as carrier for DNA delivery. J Control Release. 60:249–259.
  • Hui H, Xiao-dong F, Zhong-lin C. 2005. Thermo and pH sensitive dendrimer derivatives with a shell of poly (N,N-dimethyl aminoethyl methacrylate) and study of their controlled drug release behaviour. Polymer. 46:9514–9522.
  • Johansson E, Choi E, Angelos S, Liong M, Zink JI. 2008. Light-activated functional mesostructured silica. J Sol–Gel Sci Technol. 46:313–322.
  • Kavitha K, Rajas NJ. 2011. Sustained ophthalmic delivery of levofloxacin hemihydrate from an ion activated in situ gelling system. Int J PharmTech Res. 3:702–706.
  • Kim SW, Paii CM, Kimiko M, Seminoff LA, Holmberg DL, Gleeson JM, et al. 1990. Self-regulated glycosylated insulin delivery. J Control Release. 11:193–201.
  • Kojima C. 2010. Design of stimuli-responsive dendrimers. Expert Opin Drug Deliv. 7:307–319.
  • Kono K, Ozawa T, Yoshida T, Ozaki F, Ishizaka Y, Maruyama K, et al. 2010. Highly temperature-sensitive liposomes based on a thermosensitive block copolymer for tumor-specific chemotherapy. Biomaterials. 31:7096–7105.
  • Lai PS, Lou PJ, Peng CL, Pai CL, Yen WN, Huang MY, et al. 2007. Doxorubicin delivery by polyamidoamine dendrimer conjugation and photochemical internalization for cancer therapy. J Control Release. 122:39–46.
  • Lapeyre V, Ancla C, Catargi B, Ravaine V. 2008. Glucose-responsive microgels with a core-shell structure. J Colloid Interface Sci. 327:316–323.
  • Li AA, Shen F, Zhang T, Cirone P, Potter M, Chang PL. 2006. Enhancement of myoblast microencapsulation for gene therapy. J Biomed Mater Res Part B. 77:296–306.
  • Li C, Wallace S. 2008. Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev. 60:886–898.
  • Lin HM, Wang WK, Hsiung PA, Shyu SG. 2010. Light-sensitive intelligent drug delivery systems of coumarin-modified mesoporous bioactive glass. Acta Biomater. 6:3256–3263.
  • Liu Y, Liu J, Zhang X, Zhang R, Huang Y, Wu C. 2010. In situ gelling gelrite/alginate formulations as vehicles for ophthalmic drug delivery. Am J Pharm Sci. 11:610–620.
  • Liu Z, Li J, Nie S, Liu H, Ding P, Pan W. 2006. Study of alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharmaceutics. 315:12–17.
  • Lopez CR, Bodmeier R. 1997. Mechanical water uptake and permeability of crosslinked chitosan glutamate and alginate films. J Control Release. 44:215–225.
  • Luo R, Li H, Lam KY. 2009. Modeling the effect of environmental solution pH on the mechanical characteristics of glucose-sensitive hydrogels. Biomaterials. 30:690–700.
  • Ma WD, Xu H, Nie SF, Pan WS. 2008. Temperature-responsive, pluronic-g-poly(acrylic acid) copolymers in situ gels for ophthalmic drug delivery: rheology, in vitro drug release, and in vivo resident property. Drug Dev Ind Pharm. 34:258–266.
  • Mageed Z, Haider M, Li D, Malley BWO, Cappello J, Ghandehari H. 2004. In vitro and in vivo evaluation of recombinant silk-elastin like hydrogels for cancer gene therapy. J Control Release. 94:433–445.
  • Mal NK, Fujiwara M, Tanaka Y. 2003. Photocontrolled reversible release of guest molecules from coumarin-modified mesoporous silica. Nature. 421:350.
  • Manickam DS, Li J, Putt DA, Zhou QH, Wu C, Lash LH, Oupicky D. 2010. Effect of innate glutathione levels on activity of redox-responsive gene delivery vectors. J Control Release. 141: 77–84.
  • Meyer M, Wagner E. 2006. pH-responsive shielding of non-viral gene vectors. Expert Opin Drug Deliv. 3:563–571.
  • Mishra DN, Gilhotra RM. 2008. Design and characterization of bioadhesive in-situ gelling ocular inserts of gatifloxacin sesquihydrate. Daru. 16:1–8.
  • Miyata T, Uragami T, Nakamae K. 2002. Biomolecule-sensitive hydrogels. Adv Drug Deliv Rev. 54:79–98.
  • Nakayama M, Okano T, Miyazaki T, Kohori F, Sakai K, Yokoyama M. 2006. Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. J Control Release. 115:46–56.
  • Namgung R, Nam S, Kim SK, Son S, Singha K, Kwon JS, et al. 2009. An acid-labile temperature-responsive sol–gel reversible polymer for enhanced gene delivery to the myocardium and skeletal muscle cells. Biomaterials. 30:5225–5233.
  • Nozawa I, Suzuki Y, Sato S, Sugibayashi K, Morimoto Y. 1991. Preparation of thermo-responsive polymer membranes. I. J Biomed Mater Res. 25:243–54.
  • Obaidat AA, Park K. 1996. Characterization of gyucose dependent gel-sol phase transition of the polymeric gluocose-concanavalin A Hydrogel system. Pharm Res. 13:989–995.
  • Sahoo SK, De TK, Ghosh PK, Maitra A. 1998. pH and thermo sensitive hydrigel nanoparticles. J Colloid Inerface Sci. 206:361–368.
  • Schmaljohann D. 2006. Thermo- and pH-responsive polymers in drug delivery. Adv Drug Deliver Rev. 58:1655–1670.
  • Seminoff LA, Olsen GB, Kim SW. 1989. A Self-regulating insulin delivery system. I. Characterization of a synthetic glycosylated insulin derivative. Int J Pharm. 54:241–249.
  • Sergeeva A, Kolonin MG, Molldrem JJ, Pasqualini R, Arap W. 2006. Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev. 58:1622–1654.
  • Shenoy D, Little S, Langer R, Amiji M. 2005. Poly (ethylene oxide) modified poly (beta-amino ester) nanoparticles as a pH-sensitive system for tumor targeted delivery of hydrophobic drugs: Part 2 In vivo distribution tumor localization studies. Pharm Res. 22:2107.
  • Shigeta K, Kawakami S, Higuchi Y, Okuda T, Yagi H, Yamashita F, Hashida M. 2007. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG 2 cells. J Control Release. 118:262–270.
  • Sortino S. 2008. Nanostructured molecular films and nanoparticles with photoactivable functionalities. Photochem Photobiol Sci. 7:911–924.
  • Strehl C, Gaberm T, Jakstadt M, Hahne M, Hoff P, Spies CM, et al. 2013. High-sensitivity immunofluorescence staining: a comparison of the liposome procedure and the FASER technique on mGR detection. J Fluoresc. 23:509–518.
  • Sultana Y, Aqil M, Ali A. 2006. Ion-Activated, Gelrite based in situ ophthalmic gels of Pefloxacin Mesylate: comparison with conventional eye drops. Drug Deliv. 13:215–219.
  • Sun G, Zhang X, Shen YI, Sebestian R, Dickinson RE, Talbot FK, et al. 2011. Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during wound healing. Annu Rev. 20975–20980.
  • Tao W, Xiaobo HU, XinXing LIU, Zhen T. 2012. Mechanical behavior and stimuli-response of nanocomposite hydrogels. Scientia Sinica Chimica. 42:650–660.
  • Traitel T, Cohen Y, Kost J. 2000. Characterization of glucose-sensitive insulin release systems in simulated in vivo conditions. Biomaterials. 21:1679–1687.
  • Ueno H, Mori T, Fujinaga T. 2001. Topical formulation and wound healing applications of chitosan. Adv Drug Deliv Rev. 52:105–115.
  • Vodithala S, Khatry S, Shastri N, Sadanandam M. 2010. Formulation and evaluation of ion activated ocular gels of ketorolac tromethamine. Int J Curr Pharm Res. 2:33–38.
  • Vodovozova, E.L., Gayenko, G.P., Razinkov, V.I., Korchagina, E.Y., Bovin NV, Molotkovsky JG. 1998. Saccharide-assisted delivery of cytotoxic liposomes to human malignant cells. Biochem Mol Biol Int. 44:543–553.
  • Vyas SP, Khar RK. 2002. Targeted and controlled drug delivery of novel carrier system. CBS Publishers and Distributors Ltd, 369–370.
  • Wagnor E. 2007. Programmed drug delivery: nanosystems for tumor targeting. Expert Opin Biol Ther. 7:587–593.
  • Yong-Hee K, Bae YH, Kim SW. 1994. pH/temperature-sensitive polymers for macromolecular drug loading and release. J Control Release. 28:143–152.
  • Zhang L, Li K, Xiao W, Zheng L, Xiao Y, Fan H, Zhang X. 2011. Preparation of collagen–chondroitin sulfate–hyaluronic acid hybrid hydrogel scaffolds and cell compatibility in vitro. Carbohydr Polym. 84:118–125.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.